Shares of Gritstone Oncology Inc. (GRTS), a clinical-stage biotechnology company, have rallied 26 percent so far this month in the run-up to the presentation at the European Society for Medical Oncology's Immuno-Oncology Congress (ESMO-IO) on December 12, 2019.
from RTT - Biotech https://ift.tt/2YACYDM
via IFTTT
No comments:
Post a Comment